KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,439 | +7.4% | 41,895 | +0.4% | 0.00% | – |
| Q2 2023 | $375,579 | +123040.7% | 41,731 | +7.5% | 0.00% | – |
| Q1 2023 | $305 | +20.1% | 38,822 | +3.3% | 0.00% | – |
| Q4 2022 | $254 | -100.0% | 37,585 | +0.2% | 0.00% | -100.0% |
| Q3 2022 | $544,000 | +59.5% | 37,513 | +8.2% | 0.00% | – |
| Q2 2022 | $341,000 | +4.6% | 34,669 | +56.5% | 0.00% | – |
| Q1 2022 | $326,000 | +29.4% | 22,150 | +16.3% | 0.00% | – |
| Q4 2021 | $252,000 | -24.3% | 19,050 | -0.1% | 0.00% | – |
| Q3 2021 | $333,000 | -23.4% | 19,061 | +4.9% | 0.00% | -100.0% |
| Q2 2021 | $435,000 | -26.9% | 18,164 | -21.6% | 0.00% | 0.0% |
| Q1 2021 | $595,000 | +64.8% | 23,177 | +22.1% | 0.00% | – |
| Q4 2020 | $361,000 | +82.3% | 18,989 | +20.5% | 0.00% | – |
| Q3 2020 | $198,000 | -7.5% | 15,753 | -10.7% | 0.00% | – |
| Q2 2020 | $214,000 | +161.0% | 17,650 | +64.5% | 0.00% | – |
| Q1 2020 | $82,000 | -57.7% | 10,727 | -1.4% | 0.00% | – |
| Q4 2019 | $194,000 | +57.7% | 10,877 | +2.2% | 0.00% | – |
| Q3 2019 | $123,000 | -48.1% | 10,639 | -0.7% | 0.00% | – |
| Q2 2019 | $237,000 | – | 10,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |